From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 50s
Moderna Q3 2026 Earnings Beat
Moderna's Q3 2026 earnings beat estimates with $0.38 EPS and 29% revenue growth.
In brief
Moderna's Q3 2026 earnings beat estimates with $0.38 EPS and 29% revenue growth. Moderna returned to profitability in Q3 2026 with $1.31B revenue and 12.4% net margin after a year-over-year loss. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Q3 2026 Results
Moderna delivered GAAP EPS of $0.38 against expectations for a $1.28 loss.
Revenue Growth
Revenue reached $1.31 billion, up 29.0% year-over-year.
Net Margin Shift
Net margin swung from -19.6% to 12.4% year-over-year.
Operating Profit
Operating income of $130.0 million with 9.9% margin.
Seasonal Volatility
Q3 revenue surge follows Q2 trough due to respiratory vaccine cycles.
Capital Raise
Raised $3 billion through 0% convertible note debt.
Stock Reaction
Stock dropped 6.5% to $241.46 despite earnings beat.
What to Watch
Q4 results will determine if profitability sustains through seasonal cycles.
The bottom line
Moderna returned to profitability in Q3 2026 with $1.31B revenue and 12.4% net margin after a year-over-year loss.
